Kuwait
Kuwait
Explore linked clinical trials.16 results · Page 1 of 1
Cities
Swipe the table sideways for more columns.
| Cities | City | Country | Linked trials |
|---|---|---|---|
| Al Ahmadi | Al Ahmadi | Kuwait | 1 |
| Al Jahra | Al Jahra | Kuwait | 1 |
| Andalusia | Andalusia | Kuwait | 1 |
| Ash Shuwaykh | Ash Shuwaykh | Kuwait | 1 |
| Hadiya | Hadiya | Kuwait | 1 |
| Hawalli | Hawalli | Kuwait | 2 |
| Kuwait | Kuwait | Kuwait | 1 |
| Kuwait City | Kuwait City | Kuwait | 1 |
| Kuwait City | Kuwait City | Kuwait | 1 |
| Kuwait City | Kuwait City | Kuwait | 23 |
| Kuwait City | Kuwait City | Kuwait | 1 |
| Kuwait City | Kuwait City | Kuwait | 2 |
| Multiple Locations | Multiple Locations | Kuwait | 1 |
| Safat | Safat | Kuwait | 1 |
| Safat | Safat | Kuwait | 1 |
| Sulaibikat | Sulaibikat | Kuwait | 1 |
37 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EXtubation Related Complications - the EXTUBE Study (EXTUBE) | Extubation | Recruiting | Not stated | 2026-10-09 | NCT06442930 | |
| Enlighten Study: The EV-ICD Post Approval Registry | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, cardiovascular disorder, heart disorder | Active, not recruiting | Not stated | 2026-10-08 | NCT06048731 | |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Active, not recruiting | Phase 3 | 2026-09-24 | NCT03958877 | |
| A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region | Diffused Large B Cell Lymphoma; Hematology | Recruiting | Not stated | 2026-09-23 | NCT07065344 | |
| Product Surveillance Registry | Aneurysm, Arterial Occlusive Diseases, Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, arteriosclerosis disorder, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, coronary artery disorder, heart disorder, intracranial arterial disease, kidney disorder, kidney failure, myocardial ischemia, nervous system disorder, otorhinolaryngologic disease, urinary system disorder, vascular disorder | Recruiting | Not stated | 2026-09-18 | NCT01524276 | |
| A Multicenter Randomized Cross-Over Study Evaluating the Efficacy and Safety of Silodosin in Adult Women With Voiding Dysfunction | Female LUTS; Voiding Dysfunction | Not yet recruiting | Phase 2 | 2026-09-16 | NCT07822113 | |
| CHARM Hepatocellular Carcinoma MEA Study | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not stated | 2026-09-03 | NCT07650773 | |
| INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Not stated | 2026-09-01 | NCT06314282 | |
| Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products | Arrhythmias, Cardiac, Bradycardia, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, Tachycardia, Sinus, Tachycardia, Supraventricular, cardiovascular disorder, heart disorder, heart failure | Recruiting | Not stated | 2026-08-20 | NCT00271180 | |
| A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East | β-thalassemia | Recruiting | Not stated | 2026-08-19 | NCT07215975 | |
| Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF) | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Not applicable | 2026-08-19 | NCT07038473 | |
| Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in Kuwait | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not applicable | 2026-08-17 | NCT07766538 | |
| Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Active, not recruiting | Not stated | 2026-08-06 | NCT03992417 | |
| Fibrosis Lessens After Metabolic Surgery | Body Weight, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 4 | 2026-07-31 | NCT06374875 | |
| Dapagliflozin Plus Pioglitazone in T1DM | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Active, not recruiting | Phase 4 | 2026-07-29 | NCT03878459 | |
| Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not applicable | 2026-07-08 | NCT07574723 | |
| Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Active, not recruiting | Not stated | 2026-07-01 | NCT03932201 | |
| Pompe Disease Registry Protocol | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, disorder of glycogen metabolism, glycogen storage disease II, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, nervous system disorder | Recruiting | Not stated | 2026-06-23 | NCT00231400 | |
| Standardising Terminology, Classification, Diagnostic Recognition and Reporting of Patient-ventilator Interactions: Protocol for an International Delphi Consensus Study | Pathological Conditions, Signs and Symptoms, Patient-Ventilator Asynchrony, Respiration Disorders, Signs and Symptoms, Signs and Symptoms, Respiratory, respiratory failure, respiratory system disorder | Enrolling by invitation | Not stated | 2026-06-12 | NCT07638540 | |
| Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry | CD4+/CD56+ hematodermic neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, lymphoma, malignant histiocytosis, neoplasm, skin disorder, skin neoplasm | Recruiting | Not stated | 2026-06-05 | NCT05430971 | |
| LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not applicable | 2026-04-21 | NCT06885736 | |
| Tirzepatide Use in People With Obesity and Type 1 Diabetes | Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 4 | 2026-04-20 | NCT07096908 | |
| International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Gaucher disease, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hereditary disease, inborn errors of metabolism, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, sphingolipidosis | Recruiting | Not stated | 2026-04-14 | NCT00358943 | |
| Dapagliflozin Effect on Glucose Variability in Patients Post Bariatric Surgery | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Enrolling by invitation | Phase 2 | 2026-04-07 | NCT07515391 | |
| Micra Transcatheter Pacing System Post-Approval Registry | Arrhythmias, Cardiac, Bradycardia, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder | Active, not recruiting | Not stated | 2026-02-04 | NCT02536118 |